MedTrace Logo

Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism on Healthy Subjects

NCT02487680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-05-12

No results posted yet for this study

Summary

It has previously been shown in healthy overweight subjects, that table water including a defined amount of amino acids and chromium can decrease the postprandial glucose. In this study, the effect of this table water on glucose excursions after a test meal containing a defined amount of available carbohydrates, protein and fat will be studied in healthy subjects. The study will be conducted in a cross -over design, double blinded and placebo controlled including 20 participants. The primary endpoint of the study is the incremental area under the curve for plasma glucose (iAUCgluc) within 180 minutes after ingestion of the meal.

Conditions

Interventions

DIETARY_SUPPLEMENT

Amino Acids and chromium-picolinate containing drink

Evaluation of the dietary supplement drink containing amino acids and chromium picolinate and aroma

DIETARY_SUPPLEMENT

Placebo drink

Evaluation of the placebo supplement drink containing only aroma

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • DoubleGood AB

    lead INDUSTRY

Principal Investigators

  • Per Humpert, MD, Prof · Stoffwechselzentrum Rhein Pfalts, Mannheim, Germany and Department of internal medicine, University of Heidelberg, Germany

  • Ana Rascón, PhD, Prof · Food for Health Science Center, Lund University, Sweden

  • Kristina Andersson, PhD · Experimental Medical Science, Lund University, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-09-30
Completion
2015-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02487680 on ClinicalTrials.gov